Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Twenty-four patients with acute promyelocytic leukemia (APL) were treated with all-trans retinoic acid (45 to 100 mg/m2/day). Of these, eight cases had been either nonresponsive or resistant to previous chemotherapy; the other 16 cases were previously untreated. All patients attained complete remission without developing bone marrow hypoplasia. Bone marrow suspension cultures were studied in 15 of the 24 patients. Fourteen of these patients had morphological maturation in response to the retinoic acid (1 mumol/L). Chloroacetate esterase and alpha-naphthyl acetate esterase staining as well as electronmicroscopic examination confirmed that retinoic acid-induced cells differentiated to granulocytes with increased functional maturation (as measured by nitroblue tetrazolium reduction, NBT). The single nonresponder to retinoic acid in vitro was resistant to treatment with retinoic acid but attained complete remission after addition of low-dose cytosine arabinoside (ara-C). During the course of therapy, none of the patients showed any abnormalities in the coagulation parameters we measured, suggesting an absence of any subclinical disseminated intravascular coagulation. The only side effects consisted of mild dryness of the lips and skin, with occasional headaches and digestive symptoms. Eight patients have relapsed after 2 to 5 months of complete remission. The others remain in complete remission at 1+ to 11+ months and are still being followed up. We conclude that all-trans retinoic acid is an effective inducer for attaining complete remission in APL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bennett, J. M., Catovsky, D., Daniel, M., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb03563.x · Cited by 5,602
Cytochemical Identification of Monocytes and Granulocytes
Yam, L. T., Li, C. Y., & Crosby, W. H. (1971) · American Journal of Clinical Pathology · doi:10.1093/ajcp/55.3.283 · Cited by 2,668
Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid
Breitman, T. R., Selonick, S. E., & Collins, S. J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2936 · Cited by 1,966
Human bone marrow colony growth in agar‐gel
Pike, B. L., & Robinson, W. A. (1970) · Journal of Cellular Physiology · doi:10.1002/jcp.1040760111 · Cited by 1,273
Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications
Koeffler, H. (1983) · Blood · doi:10.1182/blood.v62.4.709.709 · Cited by 583
Breitman, T., Collins, S., & Keene, B. (1981) · Blood · doi:10.1182/blood.v57.6.1000.1000 · Cited by 571
Acute Promyelocytic Leukemia: Results of Treatment by Daunorubicin
Bernard, J., Weil, M., Boiron, M., Jacquillat, C., Flandrin, G., & Gemon, M.-F. (1973) · Blood · doi:10.1182/blood.v41.4.489.489 · Cited by 338
1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
Koeffler, H. P., Hirji, K. F., & Itri, L. M. (1985) · PubMed · Cited by 322
Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations
Flynn, P., Miller, W., Weisdorf, D., Arthur, D., Brunning, R., & Branda, R. (1983) · Blood · doi:10.1182/blood.v62.6.1211.1211 · Cited by 240
General clinical toxicology of oral retinoids
Windhorst, D. B., & Nigra, T. (1982) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(82)70056-8 · Cited by 158
Nilsson, B. (1984) · British Journal of Haematology · doi:10.1111/j.1365-2141.1984.tb02910.x · Cited by 136
Acute promyelocytic leukemia in 57 previously untreated patients
Cordonnier, C., Vernant, J. P., Brun, B., Heilmann, M. G., Kuentz, M., Bierling, P., Farcet, J., Rodet, M., Duedari, N., Imbert, M., et al. (1985) · Cancer · doi:10.1002/1097-0142(19850101)55:1<18::aid-cncr2820550104>3.0.co;2-b · Cited by 134
Daenen, S., Vellenga, E., van Dobbenburgh, O., & Halie, M. (1986) · Blood · doi:10.1182/blood.v67.2.559.559 · Cited by 111
Fontana, J. A., Rogers, J. S., & Durham, J. P. (1986) · Cancer · doi:10.1002/1097-0142(19860115)57:2<209::aid-cncr2820570204>3.0.co;2-k · Cited by 79
Treatment of leukemia with low-dose ara-C: a study of 160 cases.
Degos, L., Castaigné, S., Tilly, H., Sigaux, F., & Daniel, M. (1985) · PubMed · Cited by 57
Tomonaga, M., Yoshida, Y., Tagawa, M., Jinnai, I., Kuriyama, K., Amenomori, T., Yoshioka, A., Matsuo, T., Nonaka, H., & Ichimaru, M. (1985) · Blood · doi:10.1182/blood.v66.2.350.350 · Cited by 47
Sampi, K., Honma, Y., Hozumi, M., & Sakurai, M. (1985) · Leukemia Research · doi:10.1016/0145-2126(85)90039-6 · Cited by 18
Cited by
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N 6 -Methyladenosine RNA Demethylase
Li, Z., Weng, H., Su, R., Weng, X., Zuo, Z., Li, C., Huang, H., Nachtergaele, S., Dong, L., Hu, C., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.11.017 · Cited by 1,508
Kakizuka, A., Miller, W. H., Umesono, K., Warrell, R. P., Frankel, S. R., Murty, V. V. V. S., Dmitrovsky, E., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90112-c · Cited by 1,427
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
de Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., & Dejean, A. (1991) · Cell · doi:10.1016/0092-8674(91)90113-d · Cited by 1,343
Metadata
- Authors
- Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1988-08-01
- Volume
- 72
- Issue
- 2
- Pages
- 567-572
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1554600230
- Cited by
- 2,445
- References
- 17
- FWCI
- 12.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.